Mercedes S. L.
- Country
- Spain
- Department
- Nefrología. Planta 7ª D
Research Overview
- Evaluation of CPV-104 Pharmacokinetics, Safety, and Tolerability in Healthy Subjects and Patients with C3 Glomerulopathy
- A Phase 2 Study to Evaluate the Safety and Tolerability of ADX-038 in Participants With Complement-Mediated Kidney Disease
- A Phase 2 Study to Evaluate the Efficacy and Safety of Cevostamab in Patients with Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Data & Insights
Has run more than one trial at 237 of 588 partner sites.
Specializations
Cardiovascular and Renal Research
This investigator specializes in studying atherosclerotic cardiovascular disease specifically in patients with end-stage kidney disease (ESKD) undergoing dialysis. Their research extends to inflammatory biomarkers and their relationship to cardiovascular outcomes in dialysis patients.
- Cardiovascular complications in ESKD
- Inflammatory markers in dialysis patients
- Maintenance dialysis therapy
The investigator's work focuses on evaluating novel therapeutic approaches for cardiovascular risk reduction in the dialysis population.
Chronic Kidney Disease Management
Their expertise encompasses the treatment of chronic kidney disease (CKD) with concurrent hypertension. The investigator studies innovative combination therapies aimed at slowing disease progression and improving cardiovascular outcomes.
- Blood pressure management in CKD
- Renal function preservation
- Cardiovascular risk reduction
The research focuses on evaluating therapeutic interventions that target both renal and cardiovascular endpoints in CKD patients.
Secondary Prevention Studies
The investigator conducts research in secondary prevention of vascular events in patients with moderate chronic renal disease. Their work includes evaluation of anti-inflammatory approaches for preventing cardiovascular complications.
- Cardiovascular event prevention
- Renal disease progression
- Vascular complications management
The research encompasses comprehensive evaluation of therapeutic strategies for preventing cardiovascular events in renal disease patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.